Horizon Discovery Licenses CRISPR-Cas9 Technology | GenomeWeb

NEW YORK (GenomeWeb) – Horizon Discovery today announced it has licensed technology from ERS Genomics related to the CRISRP-Cas9 gene editing system.

Under the terms of the non-exclusive agreement, Horizon can use the technology for research applications, such as the development and sale of research tools, kits, and reagents; performance of research services; development of genetically modified disease model cell lines; development and production of reference standard materials for molecular diagnostics; and internal target identification and validation research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.